PubMed:10328107 / 136-320 JSONTXT

Annnotations TAB JSON ListView MergeView

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S2","span":{"begin":0,"end":184},"obj":"Sentence"}],"text":"BACKGROUND: Arsenic trioxide (As2O3) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death (apoptosis)."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C4","span":{"begin":12,"end":36},"obj":"NP"},{"id":"C5","span":{"begin":130,"end":145},"obj":"NP"},{"id":"C6","span":{"begin":150,"end":183},"obj":"NP"}],"text":"BACKGROUND: Arsenic trioxide (As2O3) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death (apoptosis)."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T4","span":{"begin":12,"end":28},"obj":"other_organic_compound"},{"id":"T5","span":{"begin":30,"end":35},"obj":"other_organic_compound"},{"id":"T6","span":{"begin":70,"end":78},"obj":"multi_cell"},{"id":"T7","span":{"begin":84,"end":112},"obj":"other_name"},{"id":"T8","span":{"begin":150,"end":171},"obj":"other_name"},{"id":"T9","span":{"begin":173,"end":182},"obj":"other_name"}],"text":"BACKGROUND: Arsenic trioxide (As2O3) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death (apoptosis)."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T2","span":{"begin":104,"end":112},"obj":"HP_0001909"},{"id":"T1","span":{"begin":84,"end":112},"obj":"HP_0004836"}],"text":"BACKGROUND: Arsenic trioxide (As2O3) can induce clinical remission in patients with acute promyelocytic leukemia via induction of differentiation and programmed cell death (apoptosis)."}